Evaluation of fever in infants and young children

American Family Physician

Volumn 87, Issue 4, 2013, Pages 254-260

  Hamilton, Jennifer L ^a   John, Sony P ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b The Chester County Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; C REACTIVE PROTEIN; CEFIXIME; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; GENTAMICIN; MENINGITIS VACCINE; PENICILLIN DERIVATIVE; PROCALCITONIN;

ARTICLE; BACTERIAL INFECTION; BLOOD CELL COUNT; BLOOD CULTURE; CHILD HOSPITALIZATION; FECES ANALYSIS; FEVER; FOLLOW UP; HERPES SIMPLEX VIRUS; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA; LABORATORY DIAGNOSIS; LUMBAR PUNCTURE; MENINGITIS; META ANALYSIS; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; VACCINATION;

EID: 84874920582     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Jhaveri R, Byington CL, Klein JO, Shapiro ED. Management of the nontoxic-appearing acutely febrile child: a 21st century approach. J Pediatr. 2011;159 (2):181-185.
2. Chancey RJ, Jhaveri R. Fever without localizing signs in children: a review in the post-Hib and postpneumococcal era. Minerva Pediatr. 2009;61(5):489-501.
3. Vega R. Rapid viral testing in the evaluation of the febrile infant and child. Curr Opin Pediatr. 2005;17(3):363-367.
4. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children-United States, 1998-2000. MMWR Morb Mortal Wkly Rep. 2002;51(11):234-237.
5. Centers for Disease Control and Prevention. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction- eight states, 1998-2005. MMWR Morb Mortal Wkly Rep. 2008;57(6): 144-148.
6. Stoll ML, Rubin LG. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center. Arch Pediatr Adolesc Med. 2004;158(7):671-675.
7. Bilavsky E, Ashkenazi-Hoffnung L, Yarden-Bilavsky H, Amir J, Livni G. A search for the 'Holy Grail' in the evaluation of febrile neonates aged 28 days or less: a prospective study. Scand J Infect Dis. 2011; 43 (4):264-268.
8. Bressan S, Andreola B, Cattelan F, Zangardi T, Perilongo G, Da Dalt L. Predicting severe bacterial infections in well-appearing febrile neonates: laboratory markers accuracy and duration of fever. Pediatr Infect Dis J. 2010;29(3):227-232.
9. Watt K, Waddle E, Jhaveri R. Changing epidemiology of serious bacterial infections in febrile infants without localizing signs. PLoS One. 2010;5(8):e12448.
10. Wolff M, Bachur R. Serious bacterial infection in recently immunized young febrile infants. Acad Emerg Med. 2009;16(12):1284-1289.
11. Bilavsky E, Yarden-Bilavsky H, Ashkenazi S, Amir J. C-reactive protein as a marker of serious bacterial infections in hospitalized febrile infants. Acta Paediatr. 2009; 98 (11):1776-1780.
12. Rudinsky SL, Carstairs KL, Reardon JM, Simon LV, Riffenburgh RH, Tanen DA. Serious bacterial infections in febrile infants in the post-pneumococcal conjugate vaccine era. Acad Emerg Med. 2009;16(7):585-590.
13. Copp HL, Halpern MS, Maldonado Y, Shortliffe LD. Trends in hospitalization for pediatric pyelonephritis: a population based study of California from 1985 to 2006. J Urol. 2011;186(3):1028-1034.
14. Byington CL, Rittichier KK, Bassett KE, et al. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. Pediatrics. 2003;111(5 pt 1):964-968.
15. Craig JV, Lancaster GA, Taylor S, Williamson PR, Smyth RL. Infrared ear thermometry compared with rectal thermometry in children: a systematic review. Lancet. 2002;360(9333):603-609.
16. Craig JV, Lancaster GA, Williamson PR, Smyth RL. Temperature measured at the axilla compared with rectum in children and young people: systematic review. BMJ. 2000;320(7243):1174-1178.
17. Dodd SR, Lancaster GA, Craig JV, Smyth RL, Williamson PR. In a systematic review, infrared ear thermometry for fever diagnosis in children fnds poor sensitivity. J Clin Epidemiol. 2006;59(4):354-357.
18. Al-Mukhaizeem F, Allen U, Komar L, et al. Comparison of temporal artery, rectal and esophageal core temperatures in children: results of a pilot study. Paediatr Child Health. 2004;9(7):461-465.
19. Brown L, Shaw T, Moynihan JA, Denmark TK, Mody A, Wittlake WA. Investigation of afebrile neonates with a history of fever. CJEM. 2004;6(5):343-348.
20. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research [published correction appears in Ann Emerg Med. 1993;22(9):1490]. Ann Emerg Med. 1993;22(7):1198-1210.
21. Baker MD, Bell LM, Avner JR. Outpatient management without antibiotics of fever in selected infants. N Engl J Med. 1993;329(20):1437-1441.
22. Bilavsky E, Yarden-Bilavsky H, Amir J, Ashkenazi S. Should complete blood count be part of the evaluation of febrile infants aged ≤2 months? Acta Paediatr. 2010; 99 (9):1380-1384.
23. Dagan R, Sofer S, Phillip M, Shachak E. Ambulatory care of febrile infants younger than 2 months of age classifed as being at low risk for having serious bacterial infections. J Pediatr. 1988;112(3):355-360.
24. Bang A, Chaturvedi P. Yale Observation Scale for prediction of bacteremia in febrile children. Indian J Pediatr. 2009;76(6):599-604.
25. Dagan R, Powell KR, Hall CB, Menegus MA. Identifcation of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr. 1985;107(6):855-860.
26. Huppler AR, Eickhoff JC, Wald ER. Performance of low-risk criteria in the evaluation of young infants with fever: review of the literature. Pediatrics. 2010;125(2):228-233.
27. Ishimine P. Fever without source in children 0 to 36 months of age. Pediatr Clin North Am. 2006;53(2):167-194.
28. Tighe M, Roe MF. Does a teething child need serious illness excluding? Arch Dis Child. 2007;92(3):266-268.
29. Van den Bruel A, Haj-Hassan T, Thompson M, Buntinx F, Mant D; European Research Network on Recognising Serious Infection Investigators. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet. 2010;375(9717):834-845.
30. Finnell SM, Carroll AE, Downs SM; Subcommittee on Urinary Tract Infection. Technical report-diagnosis and management of an initial UTI in febrile infants and young children. Pediatrics. 2011;128 (3):e749-e770.
31. Gorelick MH, Shaw KN. Screening tests for urinary tract infection in children: a meta-analysis. Pediatrics. 1999;104(5):e54.
32. Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J. 2008; 27(4):302-308.
33. Melendez E, Harper MB. Risk of serious bacterial infection in isolated and unsuspected neutropenia. Acad Emerg Med. 2010;17(2):163-167.
34. Van den Bruel A, Thompson MJ, Haj-Hassan T, et al. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review. BMJ. 2011;342:d3082.
35. Cincinnati Children's Hospital Medical Center. Evidence-based care guideline for fever of uncertain source in infants 60 days of age or less. October 27, 2010. http://www.cincinnatichildrens.org/svc/alpha/h/health-policy/ev-based/default.htm. Accessed May 30, 2012.
36. Ishimine P. The evolving approach to the young child who has fever and no obvious source. Emerg Med Clin North Am. 2007; 25 (4): 1087-1115, v i i.
37. Banks JB, Sullo EJ, Carter L. Clinical inquiries. What is the best way to evaluate and manage diarrhea in the febrile infant? J Fam Pract. 2004; 53(12):996-999.
38. Andreola B, Bressan S, Callegaro S, Liverani A, Plebani M, Da Dalt L. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J. 2007;26(8):672-677.
39. Thayyil S, Shenoy M, Hamaluba M, Gupta A, Frater J, Verber IG. Is procalcitonin useful in early diagnosis of serious bacterial infections in children? Acta Paediatr. 2005;94 (2):155-158.
40. Olaciregui I, Hernández U, Muñoz JA, Emparanza JI, Landa JJ. Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin. Arch Dis Child. 2009;94(7):501-505.
41. Manzano S, Bailey B, Girodias JB, Galetto-Lacour A, Cousineau J, Delvin E. Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial. Am J Emerg Med. 2010;28(6):647-653.
42. Mintegi S, Benito J, Astobiza E, Capapé S, Gomez B, Eguireun A. Well appearing young infants with fever without known source in the emergency department: are lumbar punctures always necessary? Eur J Emerg Med. 2010;17(3):167-169.
43. Baraff LJ. Management of infants and young children with fever without source. Pediatr Ann. 2008;37(10):673-679.
44. Bonsu BK, Harper MB. A low peripheral blood white blood cell count in infants younger than 90 days increases the odds of acute bacterial meningitis relative to bacteremia. Acad Emerg Med. 2004;11(12):1297-1301.
45. Bonsu BK, Chb M, Harper MB. Identifying febrile young infants with bacteremia: is the peripheral white blood cell count an accurate screen? Ann Emerg Med. 2003;42(2):216-225.
46. American College of Emergency Physicians Clinical Policies Committee; American College of Emergency Physicians Clinical Policies Subcommittee on Pediatric Fever. Clinical policy for children younger than three years presenting to the emergency department with fever. Ann Emerg Med. 2003;42(4):530-545.
47. American College of Radiology. ACR Appropriateness Criteria. Fever without source-child http://www.acr.org/~/media/ACR/Documents/AppCriteria/Diagnostic/FeverWithoutSourceChild.pdf. Accessed October 12, 2012.
48. Hui C, Neto G, Tsertsvadze A, et al. Diagnosis and management of febrile infants (0-3 months). Evidence report/technology assessments, no. 205. Rockville, Md.: Agency for Healthcare Research and Quality; 2012.
49. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA. 2003;289(2):203-209.
50. James SH, Kimberlin DW, Whitley RJ. Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res. 2009;83(3):207-213.
51. Kimberlin DW, Lin CY, Jacobs RF, et al.; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Safety and effcacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108(2):230-238.
52. Benito-Fernández J, Vázquez-Ronco MA, Morteruel-Aizkuren E, Mintegui-Raso S, Sánchez-Etxaniz J, Fernández-Landaluce A. Impact of rapid viral testing for influenza A and B viruses on management of febrile infants without signs of focal infection. Pediatr Infect Dis J. 2006;25(12): 1153-1157.
53. Krief WI, Levine DA, Platt SL, et al.; Multicenter RSV-SBI Study Group of the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. Influenza virus infection and the risk of serious bacterial infections in young febrile infants. Pediatrics. 2009;124(1):30-39.
54. Levine DA, Platt SL, Dayan PS, et al.; Multicenter RSV-SBI Study Group of the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics. 2004;113(6):1728-1734.
55. Doan Q, Enarson P, Kissoon N, Klassen TP, Johnson DW. Rapid viral diagnosis for acute febrile respiratory illness in children in the emergency department. Cochrane Database Syst Rev. 2009;(4):CD006452.
56. Mintegi S, Garcia-Garcia JJ, Benito J, et al. Rapid influenza test in young febrile infants for the identification of low-risk patients. Pediatr Infect Dis J. 2009;28(11):1026-1028.
57. Ashkenazi-Hoffnung L, Livni G, Amir J, Bilavsky E. Serious bacterial infections in hospitalized febrile infants aged 90 days or younger: the traditional combination of ampicillin and gentamicin is still appropriate. Scand J Infect Dis. 2011;43(6-7):489-494.